BJ

Budala John Mercy

Active Director Director DIN 10537615
DIN 10537615 First appointment Mar 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value •••• Premium profile

About Budala John Mercy

Data last updated:

Budala John Mercy is a Director at Ethiall Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Ethiall Pharmaceuticals Private Limited reported revenue of ₹9.64 Cr (FY 2025).

DIN 10537615
Primary Designation Director
Industry Pharma
First Appointment 11 Mar 2024
Oldest Company Age 4 yrs
Largest company Ethiall Pharmaceuticals Private Limited · ₹9.64 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Mar 20242022₹9.64 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Ethiall Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Budala John Mercy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Budala John Mercy

Budala John Mercy currently holds 1 directorship: Ethiall Pharmaceuticals Private Limited (Director, since 11 Mar 2024, revenue ₹9.64 Cr (FY 2025)).

Budala John Mercy was first appointed on 11 Mar 2024 as Director at Ethiall Pharmaceuticals Private Limited.

The current boards of Budala John Mercy's companies include Abdul Jaleel Angadi Karanakath (Ethiall Pharmaceuticals Private Limited), Cheriyeri Peediyekkal Iza Fathima (Ethiall Pharmaceuticals Private Limited), Fidha Fathima (Ethiall Pharmaceuticals Private Limited), Rahmath (Ethiall Pharmaceuticals Private Limited), Shameera (Ethiall Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available